A Golden Era of Nobel Laureates.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

A Golden Era of Nobel Laureates.Pdf PERSPECTIVES HISTORY OF SCIENCE What conditions in the 1960s enabled nine physicians who trained at NIH to A Golden Era of Nobel Laureates win Nobel Prizes? Joseph L. Goldstein and Michael S. Brown he award of the 2012 Nobel Prize in Chemistry to Robert Lefkowitz brings to nine the number of Nobel laureates T Year of who trained in research at the United States Nobel laureate NIH mentor Institute Nobel Discovery National Institutes of Health (NIH) between Prize 1964 and 1972—a remarkable outpouring Michael S. Brown Earl Stadtman NHLBI 1985 LDL receptors over such a short period from a single bio- Joseph L. Goldstein Marshall Nirenberg NHLBI 1985 LDL receptors medical institution (see the figure). Was J. Michael Bishop Leon Levintow NIAID 1989 Cellular oncogenes there something particular about these recip- ients, the time, and the place that account for Harold E. Varmus Ira Pastan NIDDK 1989 Cellular oncogenes this unprecedented record? Alfred G. Gilman Marshall Nirenberg NHLBI 1994 G proteins We were among the nine, and the paral- Stanley B. Prusiner Earl Stadtman NHLBI 1997 Prions lels in our experiences are striking. All of Ferid Murad Martha Vaughan NHLBI 1998 Nitric oxide signaling us graduated from medical school before Richard Axel Gary Felsenfeld NIDDK 2004 Odorant receptors entering NIH, and all (except Alfred Gil- Robert J. Lefkowitz Jesse Roth and NIDDK 2012 G protein–coupled receptors man) took residency training. Gilman and Ira Pastan Ferid Murad were the only M.D.-Ph.D.s in the group. For the rest of us, NIH pro- on February 6, 2013 vided our fi rst intense research experience. The Nobel nine. Listed are the Nobel Prize winners who trained at NIH in the years 1964 to 1972. NHLBI, Some of our mentors were Ph.D.s and some National Heart, Lung, and Blood Institute; NIAID, National Institute of Allergy and Infectious Diseases; were M.D.s, but they all worked in reduc- NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases. tionist systems focused on fundamental mechanisms. The nine of us studied prob- (LDL) receptors, G protein–coupled recep- been honored with Nobel Prizes: Marshall lems ranging from protein synthesis in bac- tors, and odorant receptors], and two were Nirenberg (1968), Julius Axelrod (1970), teria to hormone receptors in animal cells. honored for discovery of receptor-signaling Christian Anfi nsen (1972), D. Carlton Gaj- Despite our clinical training and the fact mechanisms (G proteins and nitric oxide). dusek (1976), and Martin Rodbell (1994). that some of us had patient care duties, our In the nonreceptor arena, two laureates elu- Four of them were Ph.D. basic scientists, and www.sciencemag.org science was far removed from the bedside. cidated a basic mechanism of cancer, and one (Gajdusek) was a physician-scientist. The sharp contrast between the uncertain- one discovered a new form of infectious neu- All fi ve were dominant forces at NIH when ties of the bedside and the relatively “pris- rologic disease. Although none of us per- we nine were there. tine” world of the laboratory provided the formed “translational research,” as currently Scores of distinguished scientists were stimulus that drove us to pursue careers in in vogue, our discoveries infl uenced drug dis- trained at NIH in the 1960s, including many fundamental research. covery, medical practice, and human health. who earned election to the U.S. National The research experience at NIH in the It is not a coincidence that the 1960s was Academy of Sciences. Others achieved dis- Downloaded from 1960s was intense. Distractions were few. the decade of the Vietnam War and the doc- tinction in other ways. Indeed, a substantial Many of us knew each other, had heated dis- tor draft. Service at NIH substituted for mili- portion of the faculties of American medi- cussions about our research, and wondered tary service in Vietnam, which led some of cal schools trained at NIH in this remark- whether we had the ability to succeed in a us to apply to NIH instead of an academic able period. laboratory-based career. institution. The draft exemption evoked a Will a single biomedical institution ever After fi nishing our training, it is surpris- huge increase in the number of applicants again train nine Nobel laureates in a sin- ing that none of us stayed at NIH. We either for NIH fellowships. As a result, NIH had its gle decade? Under the current conditions, joined clinical departments or basic science pick of fellows with the strongest academic it seems unlikely. The focus of medical departments in medical schools. Regard- records. While these factors were impor- schools in the United States has changed. In less, we all addressed fundamental problems tant, they would have amounted to nothing if the 1960s, basic science was at the core of that were relevant to medicine, making pri- we had not encountered the excitement and medical education. The brightest graduates mary use of the tools of biochemistry, sup- rigor then in place at NIH. were expected to advance their discipline plemented with molecular biology as those As research fellows at NIH, we trained through scientifi c investigation. Today, med- methods became available. It is noteworthy with brilliant scientists who had been ical school curricula tend to condense basic SCIENCE that four of us received our prizes for dis- appointed in previous years. Credit is due to science teaching to a few months instead of covery of receptors [low-density lipoprotein the courageous leaders of the various insti- the traditional two preclinical years, and the tutes who chose to appoint basic scientists courses focus on a restricted set of disease- Department of Molecular Genetics, University of Texas even when their work did not deal directly relevant “facts” with little to no discussion Southwestern Medical Center, Dallas, TX 75390–9046, USA. E-mail: [email protected]; joe. with the disease-oriented mission of the about where those facts came from or that CREDIT: Y. HAMMOND/ Y. CREDIT: [email protected] institute. Five NIH-career scientists have facts will change as science advances. The www.sciencemag.org SCIENCE VOL 338 23 NOVEMBER 2012 1033 Published by AAAS PERSPECTIVES joy of fi nding new facts or overturning old logical mechanisms. Current emphasis on and be inspired by brilliant mentors? If it ones is no longer transmitted to students. “translational research” relegates basic sci- were to happen, it would require NIH to sup- As well, clinical departments have ence to a back burner. What has been lost port teaching and research at a concentrated expanded geometrically as medical schools is the conviction that progress in medicine depth in the basic sciences to open the eyes compete with private hospitals by amass- rests ultimately on a fundamental under- of medical school graduates to the joy of sci- ing huge clinical programs. The few scien- standing of physiology. Individual curiosity- entifi c study. tifi cally oriented faculty in clinical depart- driven science has been replaced by large There is a lesson from this golden era ments have been diluted to irrelevance by consortia dedicated to the proposition that of NIH: Ambitious young physicians jux- pure clinicians. No wonder that few medi- gathering vast amounts of correlative data taposed to cutting-edge basic scientists can cal students are choosing to follow paths in will somehow provide the answer to life’s themselves make fundamental discoveries. basic research. fundamental questions. Hopefully, this lesson will help to reconfi g- The research emphasis of NIH has grad- Is it likely that the best and brightest ure the future. ually shifted. The primary focus is no longer medical students can be funneled into set- on acquisition of knowledge in basic bio- tings where they can reinforce each other 10.1126/science.1231699 AGRICULTURE Biochar—a material related to charcoal—has Carbon Storage with Benefi ts the potential to benefi t farming as well as mitigate climate change. Saran P. Sohi iochar is the solid, carbon- and displace the use of fossil fuel. rich product of heating For biochar to become the better on February 6, 2013 Bbiomass with the exclusion option, the effi cient stabilization of of air (pyrolysis or “charring”). carbon into biochar must be com- If added to soil on a large scale, bined with the recovery of energy biochar has the potential to both from pyrolysis gases and residual benefit global agriculture and heat ( 2, 4). Pyrolysis systems that mitigate climate change. It could connect continuous biochar pro- also provide an income stream duction (for example, in rotating from carbon abatement for farm- kilns) with power generation from ers worldwide. However, biochar coproducts remain scarce. www.sciencemag.org properties are far from uniform, Without financial incentives and biochar production technolo- Biochar variation. The diverse properties of biochar have led to widely vary- for carbon abatement by stabili- gies are still maturing. Research is ing results. A more systematic understanding is now emerging, helping to zation, biochar has to be worth beginning to point the way toward defi ne its value in crop production and carbon storage. money in the soil. However, bio- a targeted application of biochar char materials are diverse (see the to soils that maximizes its benefi ts. humans ( 1). Diverting a few percent of this fi gure), and maximizing the benefi ts gained Incentives for using biomass to mitigate growth into biochar production could sus- from their use depends on matching them Downloaded from climate change currently focus on replacing tainably expand biosphere carbon stocks by a to the right situation ( 5). This diversity is fossil fuels in combustion. Biochar produc- gigatonne [109 metric tons (t)] each year ( 2).
Recommended publications
  • Die Woche Spezial
    In cooperation with DIE WOCHE SPEZIAL >> Autographs>vs.>#NobelSelfie Special >> Big>Data>–>not>a>big>deal,> Edition just>another>tool >> Why>Don’t>Grasshoppers> Catch>Colds? SCIENCE SUMMIT The>64th>Lindau>Nobel>Laureate>Meeting> devoted>to>Physiology>and>Medicine More than 600 young scientists came to Lindau to meet 37 Nobel laureates CAREER WONGSANIT > Women>to>Women: SUPHAKIT > / > Science>and>Family FOTOLIA INFLAMMATION The>Stress>of>Ageing > FLASHPICS > / > MEETINGS > FOTOLIA LAUREATE > CANCER RESEARCH NOBEL > LINDAU > / > J.>Michael>Bishop>and GÄRTNER > FLEMMING > JUAN > / the>Discovery>of>the>first> > CHRISTIAN FOTOLIA Human>Oncogene EDITORIAL IMPRESSUM Chefredakteur: Prof. Dr. Carsten Könneker (v.i.S.d.P.) Dear readers, Redaktionsleiter: Dr. Daniel Lingenhöhl Redaktion: Antje Findeklee, Jan Dönges, Dr. Jan Osterkamp where>else>can>aspiring>young>scientists> Ständige Mitarbeiter: Lars Fischer Art Director Digital: Marc Grove meet>the>best>researchers>of>the>world> Layout: Oliver Gabriel Schlussredaktion: Christina Meyberg (Ltg.), casually,>and>discuss>their>research,>or>their> Sigrid Spies, Katharina Werle Bildredaktion: Alice Krüßmann (Ltg.), Anke Lingg, Gabriela Rabe work>–>or>pressing>global>problems?>Or> Verlag: Spektrum der Wissenschaft Verlagsgesellschaft mbH, Slevogtstraße 3–5, 69126 Heidelberg, Tel. 06221 9126-600, simply>discuss>soccer?>Probably>the>best> Fax 06221 9126-751; Amtsgericht Mannheim, HRB 338114, UStd-Id-Nr. DE147514638 occasion>is>the>annual>Lindau>Nobel>Laure- Geschäftsleitung: Markus Bossle, Thomas Bleck Marketing und Vertrieb: Annette Baumbusch (Ltg.) Leser- und Bestellservice: Helga Emmerich, Sabine Häusser, ate>Meeting>in>the>lovely>Bavarian>town>of> Ute Park, Tel. 06221 9126-743, E-Mail: [email protected] Lindau>on>Lake>Constance. Die Spektrum der Wissenschaft Verlagsgesellschaft mbH ist Kooperati- onspartner des Nationalen Instituts für Wissenschaftskommunikation Daniel>Lingenhöhl> GmbH (NaWik).
    [Show full text]
  • Lecture Program
    EARL W. SUTHERLAND LECTURE EARL W. SUTHERLAND LECTURE The Earl W. Sutherland Lecture Series was established by the SPONSORED BY: Department of Molecular Physiology and Biophysics in 1997 DEPARTMENT OF MOLECULAR PHYSIOLOGY AND BIOPHYSICS to honor Dr. Sutherland, a former member of this department and winner of the 1971 Nobel Prize in Physiology or Medicine. This series highlights important advances in cell signaling. ROBERT J. LEFKOWITZ, MD NOBEL PRIZE IN CHEMISTRY, 2012 SPEAKERS IN THIS SERIES HAVE INCLUDED: SEVEN TRANSMEMBRANE RECEPTORS Edmond H. Fischer (1997) Alfred G. Gilman (1999) Ferid Murad (2001) Louis J. Ignarro (2003) MARCH 31, 2016 Paul Greengard (2007) 4:00 P.M. 208 LIGHT HALL Eric Kandel (2009) Roger Tsien (2011) Michael S. Brown (2013) 867-2923-Institution-Discovery Lecture Series-Lefkowitz-BK-CH.indd 1 3/11/16 9:39 AM EARL W. SUTHERLAND, 1915-1974 ROBERT J. LEFKOWITZ, MD JAMES B. DUKE PROFESSOR, Earl W. Sutherland grew up in Burlingame, Kansas, a small farming community DUKE UNIVERSITY MEDICAL CENTER that nourished his love for the outdoors and fishing, which he retained throughout INVESTIGATOR, HOWARD HUGHES MEDICAL INSTITUTE his life. He graduated from Washburn College in 1937 and then received his MEMBER, NATIONAL ACADEMY OF SCIENCES M.D. from Washington University School of Medicine in 1942. After serving as a MEMBER, INSTITUTE OF MEDICINE medical officer during World War II, he returned to Washington University to train NOBEL PRIZE IN CHEMISTRY, 2012 with Carl and Gerty Cori. During those years he was influenced by his interactions with such eminent scientists as Louis Leloir, Herman Kalckar, Severo Ochoa, Arthur Kornberg, Christian deDuve, Sidney Colowick, Edwin Krebs, Theodore Robert J.
    [Show full text]
  • Nobel Laureates Endorse Joe Biden
    Nobel Laureates endorse Joe Biden 81 American Nobel Laureates in Physics, Chemistry, and Medicine have signed this letter to express their support for former Vice President Joe Biden in the 2020 election for President of the United States. At no time in our nation’s history has there been a greater need for our leaders to appreciate the value of science in formulating public policy. During his long record of public service, Joe Biden has consistently demonstrated his willingness to listen to experts, his understanding of the value of international collaboration in research, and his respect for the contribution that immigrants make to the intellectual life of our country. As American citizens and as scientists, we wholeheartedly endorse Joe Biden for President. Name Category Prize Year Peter Agre Chemistry 2003 Sidney Altman Chemistry 1989 Frances H. Arnold Chemistry 2018 Paul Berg Chemistry 1980 Thomas R. Cech Chemistry 1989 Martin Chalfie Chemistry 2008 Elias James Corey Chemistry 1990 Joachim Frank Chemistry 2017 Walter Gilbert Chemistry 1980 John B. Goodenough Chemistry 2019 Alan Heeger Chemistry 2000 Dudley R. Herschbach Chemistry 1986 Roald Hoffmann Chemistry 1981 Brian K. Kobilka Chemistry 2012 Roger D. Kornberg Chemistry 2006 Robert J. Lefkowitz Chemistry 2012 Roderick MacKinnon Chemistry 2003 Paul L. Modrich Chemistry 2015 William E. Moerner Chemistry 2014 Mario J. Molina Chemistry 1995 Richard R. Schrock Chemistry 2005 K. Barry Sharpless Chemistry 2001 Sir James Fraser Stoddart Chemistry 2016 M. Stanley Whittingham Chemistry 2019 James P. Allison Medicine 2018 Richard Axel Medicine 2004 David Baltimore Medicine 1975 J. Michael Bishop Medicine 1989 Elizabeth H. Blackburn Medicine 2009 Michael S.
    [Show full text]
  • American Researchers Richard Axel and Linda B. Buck Were the Winners
    NOSSA CAPA OUR MAGAZINE J Bras Patol Med Lab • Volume 40 • Número 6 • Dezembro 2004 ISSN 1676-2444 • Volume 40 • NúmeroISSN 1 • Março 1676-2444 2004 COVER Richard Axel e Linda B. Buck, ganhadores do Prêmio Nobel de Medicina de 2004 importantes do olfato, um campo em que as pesquisas em todo o mundo estavam atrasadas em relação aos estudos dos demais sentidos. A descoberta dos cientistas reafirma a importância do Press sistema olfativo na qualidade de vida do homem e no sen- Folha Folha tido do paladar. O porta-voz do Instituto Karolinska disse oto: oto: F que “um bom vinho ou um morango maduro nos ajuda a detectar as qualidades que consideramos positivas. Um odor singular pode despertar velhas recordações”. Os princípios desvendados por Axel e Buck para o sistema olfativo também podem ser aplicados a outros sentidos. Os norte-americanos Richard Axel e Linda B. Buck foram os Afinal, os feromônios, cujo papel é importante no com- ganhadores do Prêmio Nobel de Medicina de 2004 pelos portamento social e sexual dos animais, são moléculas seus estudos sobre os receptores olfativos e a organização também detectadas por receptores igualmente localiza- do sistema olfativo nos seres humanos. dos no epitélio nasal. Os dois pesquisadores foram premiados porque, em seus Os dois pesquisadores americanos publicaram conjunta- centros de estudos nos Estados Unidos, descobriram mente suas descobertas em 1991 e posteriormente uma grande família genética constituída por cerca de mil continuaram com as pesquisas em seus centros de genes diferentes – 3% do nosso padrão genético – que pesquisa. estão na origem de um número equivalente de tipos de Linda Buck tem 57 anos e é pesquisadora do Fred Hutch- receptores olfativos.
    [Show full text]
  • Michael S. Brown, MD
    DISTINGUISHED PHYSICIANS AND Michael S. Brown, M.D. Sir Richard Roberts, Ph.D. Winner, 1985 Nobel Prize in Physiology or Medicine Winner, 1993 Nobel Prize in Physiology or Medicine MEDICAL SCIENTISTS MENTORING Winner, 1988 Presidential National Medal of Science A globally prominent biochemist and molecular biologist, DELEGATES HAVE INCLUDED... Dr. Brown received the world’s most prestigious medical Dr. Roberts was awarded the Nobel Prize for his prize for his work describing the regulation of the groundbreaking contribution to discovering RNA splicing. cholesterol metabolism. His work laid the foundation for Dr. Roberts is dedicating his future research to GMO crops the class of drugs now called statins taken daily by more than 20 million and food sources, and demonstrating the effect they have on humanity. — GRANDg MASTERS — people worldwide. Ferid Murad, M.D., Ph.D. Mario Capecchi, Ph.D. Boris D. Lushniak, M.D., M.P.H Winner, 1998 Nobel Prize in Physiology or Medicine Academy Science Director The Surgeon General of the United States (acting, 2013-2014) Winner, 2007 Nobel Prize in Physiology or Medicine A world-renowned pioneer in biochemistry, Dr. Murad’s Winner, 2001 National Medal of Science Rear Admiral Lushniak, M.D., M.P.H., was the United award-winning research demonstrated that nitroglycerin Winner, 2001 Lasker Award States’ leading spokesperson on matters of public health, and related drugs help patients with heart conditions by Winner, 2003 Wolf Prize in Medicine overseeing the operations of the U.S. Public Health Service releasing nitric oxide into the body, thus relaxing smooth Mario Capecchi, Ph.D., a biophysicist, is a Distinguished Commissioned Corps, which consists of approximately muscles by elevating intracellular cyclic GMP, leading to vasodilation and Professor of Human Genetics at the University of Utah School of Medicine.
    [Show full text]
  • Earl W. Sutherland Lecture Earl W
    EARL W. SUTHERLAND LECTURE EARL W. SUTHERLAND LECTURE The Earl W. Sutherland Lecture Series was established by the SPONSORED BY: Department of Molecular Physiology and Biophysics in 1997 DEPARTMENT OF MOLECULAR PHYSIOLOGY AND BIOPHYSICS to honor Dr. Sutherland, a former member of this department and winner of the 1971 Nobel Prize in Physiology or Medicine. This series highlights important advances in cell signaling. MICHAEL S. BROWN, M.D NOBEL LAUREATE IN PHYSIOLOGY OR MEDICINE 1985 SPEAKERS IN THIS SERIES HAVE INCLUDED: SCAP: ANATOMY OF A MEMBRANE STEROL SENSOR Edmond H. Fischer (1997) Alfred G. Gilman (1999) Ferid Murad (2001) Louis J. Ignarro (2003) APRIL 25, 2013 Paul Greengard (2007) 4:00 P.M. 208 LIGHT HALL Eric Kandel (2009) Roger Tsien (2011) FOR MORE INFORMATION, CONTACT: Department of Molecular Physiology & Biophysics 738 Ann and Roscoe Robinson Medical Research Building Vanderbilt University Medical Center Nashville, TN 37232-0615 Tel 615.322.7001 [email protected] EARL W. SUTHERLAND, 1915-1974 MICHAEL S. BROWN, M.D. REGENTAL PROFESSOR Earl W. Sutherland grew up in Burlingame, Kansas, a small farming community that nourished his love for the outdoors and fishing, which he retained throughout DIRECTOR OF THE JONSSON CENTER FOR MOLECULAR GENETICS UNIVERSITY OF TEXAS his life. He graduated from Washburn College in 1937 and then received his M.D. SOUTHWESTERN MEDICAL CENTER AT DALLAS from Washington University School of Medicine in 1942. After serving as a medi- NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE, 1985 cal officer during World War II, he returned to Washington University to train with MEMBER, NATIONAL ACADEMY OF SCIENCES Carl and Gerty Cori.
    [Show full text]
  • Download Ps Nobel Prizes for Site BEE 11.18.16 Revised 11.30.17.Pdf
    Nobel Laureates at the College of Physicians and Surgeons For years, College of Physicians and Surgeons alumni, faculty, and researchers have led groundbreaking clinical and basic scientific studies that have transformed our understanding of human biology and advanced the practice of medicine. On many occasions, this work has been honored with the Nobel Prize. The scope of research led by P&S Nobel laureates is tremendous. Although most of our prizewinners were honored for work in physiology or medicine, a few also received the prize for chemistry. Their research has fundamentally shaped the course of numerous fields, including cardiology, neuroscience, genetics, pharmaceutical development, and more. Our Nobel laureates include: André Cournand and Dickinson Richards (P&S’23), whose work at P&S on cardiac catheterization—a method of inserting a tiny tube into the heart—provided the basis for open-heart surgery and interventional cardiology Baruch Blumberg (P&S’51), who discovered the hepatitis B virus and helped develop a test and a vaccine for the virus Joshua Lederberg, a Columbia College and P&S graduate student who showed that bacteria can exchange genes when they reproduce, creating a way to model and study genetics in higher organisms Harold Varmus (P&S’66), who demonstrated how genes in normal human and animal cells can mutate to cause cancer, leading to a new generation of research on the genetic origins of cancer Eric Kandel, current University Professor, who showed how memories are stored in nerve cells, greatly enhancing
    [Show full text]
  • 2014 Progress Report 1 2014 Xxxxx Progress X Report
    XXXXXX 2014 PROGRESS REPORT 1 2014 XXXXX PROGRESS X REPORT DARE TO LOOK BEYOND THE HORIZON 2014 PROGRESS REPORT 3 TABLE OF CONTENTS A Word from the Director 4 A Word from the Scientific Director 5 2013-2018 Strategic Research Plan 6 to 11 Discovery and Hope 12 to 17 The New CHUM Research Centre 18 and 19 The Student Environment: Excellence in the Next Generation 20 and 21 Philanthropy: Supporting Speculative Research and the Next Generation 22 and 23 2013-2014 Financial Picture 24 and 25 Our Committees 26 SEEK OUT WHAT OTHERS FEAR TO TREAD Premiers arrivants Designed expressly to overhang the FRANÇOIS VINCENT CRCHUM entrance hall, this work Painter pays homage to a more sensitive Materials: oil on panels fastened to approach to life. Its simplicity for- hardwood (ash) uprights sakes the complexity of science and Dimensions: 5 panels measuring its grandeur invites the passer-by to 1.4 m. x 1.7 m., the entire piece take a moment to contemplate and measures 5.1 m. in all and is hung look into oneself. 1.8 m. above the ground. This work was chosen within the framework of the Government’s policy geared towards integrating the arts into the architecture and built environ- ment of Government and public sites, which compels any organization that receive grants from the State to set aside at least 1% of their budget to create or purchase works of art. 4 A WORD FROM 2014 PROGRESS REPORT 5 A WORD THE DIRECTORS FROM THE DIRECTORS A WORD FROM A WORD FROM THE THE DIRECTOR SCIENTIFIC DIRECTOR fter six years of tho- possibilities for meaningful exchan- of direct investment made by the he past few years have devotion and passion.
    [Show full text]
  • The Elie Wiesel Foundation for Humanity Nobel
    THE ELIE WIESEL FOUNDATION FOR HUMANITY NOBEL LAUREATES INITIATIVE September 9, 2005 TO: Kansas State Board of Education We, Nobel Laureates, are writing in defense of science. We reject efforts by the proponents of so-called “intelligent design” to politicize scientific inquiry and urge the Kansas State Board of Education to maintain Darwinian evolution as the sole curriculum and science standard in the State of Kansas. The United States has come a long way since John T. Scopes was convicted for teaching the theory of evolution 80 years ago. We are, therefore, troubled that Darwinism was described as “dangerous dogma” at one of your hearings. We are also concerned by the Board’s recommendation of August 8, 2005 to allow standards that include greater criticism of evolution. Logically derived from confirmable evidence, evolution is understood to be the result of an unguided, unplanned process of random variation and natural selection. As the foundation of modern biology, its indispensable role has been further strengthened by the capacity to study DNA. In contrast, intelligent design is fundamentally unscientific; it cannot be tested as scientific theory because its central conclusion is based on belief in the intervention of a supernatural agent. Differences exist between scientific and spiritual world views, but there is no need to blur the distinction between the two. Nor is there need for conflict between the theory of evolution and religious faith. Science and faith are not mutually exclusive. Neither should feel threatened by the other. When it meets in October, 2005, we urge the Kansas State Board of Education to vote against the latest draft of standards, which propose including intelligent design in academic curriculum.
    [Show full text]
  • Nobel Award Stirs up Debate on Nitric Oxide Breakthrough
    news Nobel award stirs up debate on nitric oxide breakthrough [LONDON] The Nobel committee has once again sparked controversy, particularly in Britain, with the award this week of the 1998 8 prize for physiology or medicine to pharma- cologists Robert Furchgott, of the State Uni- versity of New York, Louis Ignarro, of the University of California, Los Angeles, and Ferid Murad, of University of Texas Medical SULLIVAN NADEL/PAT AP/ADAM School in Houston. No-one is disputing that the pioneering work of the three US researchers on nitric oxide as a signalling molecule in the cardio- vascular system (see box) deserves the recog- nition of the committee. But many feel that a The winners: Robert Furchgott (left), Louis Ignarro and Ferid Murad. fourth name should also have been recog- nized — that of Salvador Moncada, currently pharmacology”. Moncada’s achievements edged. But he believes that the prize is thor- director of the Wolfson Institute for Biomed- were recognized when he was elected as a oughly deserved by Furchgott — without ical Research at University College London. foreign associate of the National Academy of whom “the field would not even exist” — The controversy originates in 1987, when Sciences in 1994. The citation says that he and says that he had nominated both Furch- a paper by Ignarro confirming the identity “discovered that mammalian vascular tis- gott and Ignarro for the prize. of endothelium-derived relaxing factor sues generate nitric oxide that is biosynthe- More outspoken support for Moncada (EDRF) and nitric oxide, as had been sized from L-arginine. He elucidated the rel- comes from Nobel laureate Cesar Milstein of hypothesized separately by him and Furch- evance of this pathway as a universal trans- the MRC Laborato- UCL gott, appeared in the Proceedings of the duction mechanism for the regulation of cell ry of Molecular National Academy of Sciences (84, function and communication”.
    [Show full text]
  • ILAE Historical Wall02.Indd 10 6/12/09 12:04:44 PM
    2000–2009 2001 2002 2003 2005 2006 2007 2008 Tim Hunt Robert Horvitz Sir Peter Mansfi eld Barry Marshall Craig Mello Oliver Smithies Luc Montagnier 2000 2000 2001 2002 2004 2005 2007 2008 Arvid Carlsson Eric Kandel Sir Paul Nurse John Sulston Richard Axel Robin Warren Mario Capecchi Harald zur Hauser Nobel Prizes 2000000 2001001 2002002 2003003 200404 2006006 2007007 2008008 Paul Greengard Leland Hartwell Sydney Brenner Paul Lauterbur Linda Buck Andrew Fire Sir Martin Evans Françoise Barré-Sinoussi in Medicine and Physiology 2000 1st Congress of the Latin American Region – in Santiago 2005 ILAE archives moved to Zurich to become publicly available 2000 Zonismide licensed for epilepsy in the US and indexed 2001 Epilepsia changes publishers – to Blackwell 2005 26th International Epilepsy Congress – 2001 Epilepsia introduces on–line submission and reviewing in Paris with 5060 delegates 2001 24th International Epilepsy Congress – in Buenos Aires 2005 Bangladesh, China, Costa Rica, Cyprus, Kazakhstan, Nicaragua, Pakistan, 2001 Launch of phase 2 of the Global Campaign Against Epilepsy Singapore and the United Arab Emirates join the ILAE in Geneva 2005 Epilepsy Atlas published under the auspices of the Global 2001 Albania, Armenia, Arzerbaijan, Estonia, Honduras, Jamaica, Campaign Against Epilepsy Kyrgyzstan, Iraq, Lebanon, Malta, Malaysia, Nepal , Paraguay, Philippines, Qatar, Senegal, Syria, South Korea and Zimbabwe 2006 1st regional vice–president is elected – from the Asian and join the ILAE, making a total of 81 chapters Oceanian Region
    [Show full text]
  • Open Letter to the American People
    FOR IMMEDIATE RELEASE: October 18, 2016 AN OPEN LETTER TO THE AMERICAN PEOPLE The coming Presidential election will have profound consequences for the future of our country and the world. To preserve our freedoms, protect our constitutional government, safeguard our national security, and ensure that all members of our nation will be able to work together for a better future, it is imperative that Hillary Clinton be elected as the next President of the United States. Some of the most pressing problems that the new President will face — the devastating effects of debilitating diseases such as Alzheimer’s disease and cancer, the need for alternative sources of energy, and climate change and its consequences — require vigorous support for science and technology and the assurance that scientific knowledge will inform public policy. Such support is essential to this country’s economic future, its health, its security, and its prestige. Strong advocacy for science agencies, initiatives to promote innovation, and sensible immigration and education policies are crucial to the continued preeminence of the U.S. scientific work force. We need a President who will support and advance policies that will enable science and technology to flourish in our country and to provide the basis of important policy decisions. For these reasons and others, we, as U.S. Nobel Laureates concerned about the future of our nation, strongly and fully support Hillary Clinton to be the President of the United States. Peter Agre, Chemistry 2003 Carol W. Greider, Medicine 2009 Sidney Altman, Chemistry 1989 David J. Gross, Physics 2004 Philip W. Anderson, Physics 1977 Roger Guillemin, Medicine 1977 Kenneth J.
    [Show full text]